In Sweden, there are noticeable differences between the antenatal health care settings concerning the prevalence of oral glucose tolerance tests (OGTT) to detect gestational diabetes mellitus (GDM). Clinical guidelines for screening, diagnostics and treatment of GDM 2004 were collected from all antenatal health care areas (n=50, 100% of eligible areas) in Sweden. The guidelines were analysed in relation to the available national statistics. The most prominent finding was that there was no consensus on screening, diagnosis and treatment of GDM. In most areas, the well-known risk factors for GDM were used as the criteria for offering OGTT to pregnant women. However, some areas offered OGTT to all pregnant women, resulting in a significantly greater detection of GDM. Hence, it is likely that the reported prevalence of GDM in Sweden is an underestimate. We suggest that national guidelines for screening, diagnosis and treatment of GDM should be developed in order to better fulfil the intentions of the Swedish National Board of Health and Welfare.
Originaltitel: Sverige saknar enhetliga riktlinjer rörande graviditetsdiabetes. Screening, diagnostik och handläggning varierar stort i mödrahälsovården